BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34214127)

  • 1. Viral and immunological markers of HIV-associated Kaposi sarcoma recurrence.
    Ngalamika O; Mukasine MC; Kawimbe M; Vally F
    PLoS One; 2021; 16(7):e0254177. PubMed ID: 34214127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma: higher incidence and mortality in Africa than in the UK.
    Letang E; Lewis JJ; Bower M; Mosam A; Borok M; Campbell TB; Naniche D; Newsom-Davis T; Shaik F; Fiorillo S; Miro JM; Schellenberg D; Easterbrook PJ
    AIDS; 2013 Jun; 27(10):1603-13. PubMed ID: 23462220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar Immunological Profiles Between African Endemic and Human Immunodeficiency Virus Type 1-Associated Epidemic Kaposi Sarcoma (KS) Patients Reveal the Primary Role of KS-Associated Herpesvirus in KS Pathogenesis.
    Lidenge SJ; Tso FY; Ngalamika O; Ngowi JR; Mortazavi Y; Kwon EH; Shea DM; Minhas V; Mwaiselage J; Wood C; West JT
    J Infect Dis; 2019 Apr; 219(8):1318-1328. PubMed ID: 30452681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment response and mortality among patients starting antiretroviral therapy with and without Kaposi sarcoma: a cohort study.
    Maskew M; Fox MP; van Cutsem G; Chu K; Macphail P; Boulle A; Egger M; Africa FI
    PLoS One; 2013; 8(6):e64392. PubMed ID: 23755122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of immune reconstitution inflammatory syndrome-associated with kaposi sarcoma in mozambique: a prospective study.
    Letang E; Almeida JM; Miró JM; Ayala E; White IE; Carrilho C; Bastos R; Nhampossa T; Menéndez C; Campbell TB; Alonso PL; Naniche D
    J Acquir Immune Defic Syndr; 2010 Apr; 53(5):589-97. PubMed ID: 19801945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kaposi sarcoma: no longer an AIDS-defining illness? A retrospective study of Kaposi sarcoma cases with CD4 counts above 300/mm³ at presentation.
    Daly ML; Fogo A; McDonald C; Morris-Jones R
    Clin Exp Dermatol; 2014 Jan; 39(1):7-12. PubMed ID: 23691969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions.
    El-Mallawany NK; Mehta PS; Kamiyango W; Villiera J; Peckham-Gregory EC; Kampani C; Krysiak R; Sanders MK; Caro-Vegas C; Eason AB; Ahmed S; Schutze GE; Martin SC; Kazembe PN; Scheurer ME; Dittmer DP
    Int J Cancer; 2019 Jan; 144(1):110-116. PubMed ID: 30204240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's Sarcoma in HIV-infected patients in South Africa: Multicohort study in the antiretroviral therapy era.
    Bohlius J; Valeri F; Maskew M; Prozesky H; Garone D; Sengayi M; Fox MP; Davies MA; Egger M
    Int J Cancer; 2014 Dec; 135(11):2644-52. PubMed ID: 24729433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired immunodeficiency syndrome-related Kaposi's sarcoma regression after highly active antiretroviral therapy: biologic correlates of clinical outcome.
    Cattelan AM; Calabrò ML; Gasperini P; Aversa SM; Zanchetta M; Meneghetti F; De Rossi A; Chieco-Bianchi L
    J Natl Cancer Inst Monogr; 2001; (28):44-9. PubMed ID: 11158206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma biomarkers of clinical response during chemotherapy plus combination antiretroviral therapy (cART) in HIV+ patients with advanced Kaposi sarcoma.
    Tedeschi R; Bidoli E; Bortolin MT; Schioppa O; Vaccher E; De Paoli P
    Oncotarget; 2015 Oct; 6(30):30334-42. PubMed ID: 26296972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma.
    Ngalamika O; Tso FY; Lidenge S; Munsaka S; Shea D; Wood C; West J
    PLoS One; 2020; 15(7):e0235865. PubMed ID: 32634155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Kaposi's sarcoma-associated herpesvirus in peripheral blood cells in human immunodeficiency virus infection: association with Kaposi's sarcoma, CD4 cell count, and HIV RNA levels.
    Min J; Katzenstein DA
    AIDS Res Hum Retroviruses; 1999 Jan; 15(1):51-5. PubMed ID: 10024052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevation of soluble intercellular adhesion molecule-1 levels, but not angiopoietin 2, in the plasma of human immunodeficiency virus-infected African women with clinical Kaposi sarcoma.
    Graham SM; Rajwans N; Richardson BA; Jaoko W; McClelland RS; Overbaugh J; Liles WC
    Am J Trop Med Hyg; 2014 Oct; 91(4):705-8. PubMed ID: 25002294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin 6 and AIDS-associated Kaposi's sarcoma: a nested case control study within the Multicenter AIDS Cohort Study.
    Dourado I; Martínez-Maza O; Kishimoto T; Suzuki H; Detels R
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):781-8. PubMed ID: 9171222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission from Kaposi's sarcoma on HAART is associated with suppression of HIV replication and is independent of protease inhibitor therapy.
    Martinez V; Caumes E; Gambotti L; Ittah H; Morini JP; Deleuze J; Gorin I; Katlama C; Bricaire F; Dupin N
    Br J Cancer; 2006 Apr; 94(7):1000-6. PubMed ID: 16570046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin with antiretroviral therapy in AIDS-associated Kaposi sarcoma: an AIDS Malignancy Consortium study.
    Krown SE; Roy D; Lee JY; Dezube BJ; Reid EG; Venkataramanan R; Han K; Cesarman E; Dittmer DP
    J Acquir Immune Defic Syndr; 2012 Apr; 59(5):447-54. PubMed ID: 22067664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical application of plasma Kaposi sarcoma herpesvirus viral load as a tumour biomarker: results from 704 patients.
    Haq IU; Dalla Pria A; Papanastasopoulos P; Stegmann K; Bradshaw D; Nelson M; Bower M
    HIV Med; 2016 Jan; 17(1):56-61. PubMed ID: 26111246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Kaposi's sarcoma in sub-Saharan Africa.
    Motlhale M; Sitas F; Bradshaw D; Chen WC; Singini MG; de Villiers CB; Lewis CM; Muchengeti M; Waterboer T; Mathew CG; Newton R; Singh E
    Cancer Epidemiol; 2022 Jun; 78():102167. PubMed ID: 35504064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced levels of neutralizing antibodies to Kaposi sarcoma-associated herpesvirus in persons with a history of Kaposi sarcoma.
    Kimball LE; Casper C; Koelle DM; Morrow R; Corey L; Vieira J
    J Infect Dis; 2004 Jun; 189(11):2016-22. PubMed ID: 15143468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted Kaposi's sarcoma (KS) herpesvirus transcription in KS lesions from patients on successful antiretroviral therapy.
    Dittmer DP
    mBio; 2011; 2(6):e00138-11. PubMed ID: 22045987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.